The ScientistPatient Registries to Bolster Cell- and Gene-Therapy Clinical Trial DataThe ScientistSo far, there are about seven known cell-therapy patient outcome registries in the U.S. and Europe, and another seven documented registries that are track… Continue reading
The ScientistPatient Registries to Bolster Cell- and Gene-Therapy Clinical Trial DataThe ScientistSo far, there are about seven known cell-therapy patient outcome registries in the U.S. and Europe, and another seven documented registries that are track… Continue reading
Global Synthetic Biology Market 2018 Market Research Report Detailed Analysis & Forecast 2011-2023Expert ConsultingThe Scope of the global Synthetic Biology market mainly focuses on globally, it primarily covers the Global Synthetic Biology Market … Continue reading
Global CRISPR Technology Market – Analysis And Forecast (2018-2027)PR Newswire (press release)The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, haemophi… Continue reading
Fred Hutch News ServiceTinkering with T cellsFred Hutch News ServiceThe molecular weapons Salter is working with are artificial receptors, called chimeric antigen receptors, or CARs. Embedded in T cells, CARs and their natural cousins, T-cell receptors… Continue reading
Fred Hutch News ServiceTinkering with T cellsFred Hutch News ServiceThe molecular weapons Salter is working with are artificial receptors, called chimeric antigen receptors, or CARs. Embedded in T cells, CARs and their natural cousins, T-cell receptors… Continue reading
Endpoints News |
Seattle’s Nohla closes $45M to bring novel stem cell treatment for leukemia to late-stage trials
Endpoints News Seattle’s Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, has raised $45 million in new money to push forward its Phase II cell therapy for cord blood transplants. The new Series B, backed in part by … |